GI CONNECT has summarised the highlights of the ASCO GI 2016 meeting in San Francisco for you.
Cancers of the Upper GI tract by Dr. Hubbard
Oncology
GI CONNECT update from ASCO GI 2016
Cancers of the upper GI tract
Publication Date
Sep 2021
Dr Joleen Hubbard is Deputy Director of Clinical Research and Academic Affairs for the Allina Health Cancer Institute in Minneapolis, Minnesota. She was previously Assistant Professor of Medical Oncology at Mayo Clinic. She completed medical school and residency at the University of Minnesota and haematology/oncology training at Mayo Clinic, Rochester, Minnesota. Dr Hubbard specialises in the treatment of gastrointestinal cancers, focusing on colorectal cancer. Dr Hubbard is the PI of several phase I clinical trials, investigating novel agents for gastrointestinal cancers. Her research interests also include geriatric oncology with a special interest in clinical and biologic markers of frailty. She serves as a member of the Cancer in the Elderly, as well as the Health Reported Outcomes and Translational Research committees for the North American Alliance of Clinical Trials in Oncology Network.
Assoc. Prof. Joleen Hubbard has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Advisory boards: Bayer, Merck, BeiGene, Incyte
Research funding to institution: Merck, Boston Biomedical, Treos Bio, Senhwa Pharmaceuticals, Bayer, Incyte, TriOncology, Seattle Genetics, Hutchison MediPharma, Pionyr Immunotherapeutics, Trovogene, G1 Therapeutics, Roche
Programme summary
Duration 5 MIN
Downloadable resources Yes-
Download the slides
-
Language(s)
Share this programme
Brought to you by
GI CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Ipsen, BeiGene Europe and Pierre Fabre Laboratories.
Meet the experts
Other programmes of interest
Podcast
Hemostasis and bleeding disorders Oncology
Σειρά podcast για τη διαχείριση της θρόμβωσης
Αναλύσεις από καταξιωμένους ειδικούς ιατρούς. Πλοηγηθείτε στις καρτέλες για να επιλέξετε ένα επεισόδιο podcast
Experts
Prof. Dimitrios Tsakiris, Prof. Michael Nagler, Dr Lars Asmis, Prof. Jerzy Windyga-
Downloadable
Resources -
27 MIN
-
Feb 2025
Conference update
Oncology
ESMO Virtual Plenary: Final OS results from the phase III TROPION-Breast01 trial
How will the latest Dato-DXd data impact treatment strategies for HR+/HER2− mBC?
Experts
Prof. François-Clément Bidard, Dr Barbara Pistilli-
5 MIN
-
Feb 2025
Podcast
Oncology Obstetrics and Gynecology
Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions
Understanding the role of molecular subtypes in guiding treatment selection
Experts
Prof. Xavier Matias-Guiu, Dr Jurjees HasanEndorsed by
-
Downloadable
Resources -
11 MIN
-
Feb 2025
Podcast
Hemostasis and bleeding disorders Oncology
Postępowanie w przypadku zakrzepicy – seria podcastów
Uznani eksperci dzielą się swoimi spostrzeżeniami. Kliknij na odpowiednią zakładkę, aby wybrać odcinek podcastu.
Experts
Prof. Dimitrios Tsakiris, Prof. Michael Nagler, Dr Lars Asmis, Prof. Jerzy Windyga-
Downloadable
Resources -
27 MIN
-
Feb 2025
Conference update
Oncology
Highlights from ASCO GI 2025
Expert insights on BRAF-mutated colorectal cancer
Experts
Dr Elena ÉlezEndorsed by
-
Downloadable
Resources -
5 MIN
-
Feb 2025
Podcast
Episode
4
of 4
Oncology
HCC podcast series part 4: Intermediate HCC – the evolving role of IO
Integrating multimodal approaches with multidisciplinary care
Experts
Dr Edward Kim, Dr Nina Sanford, Dr Mark Yarchoan, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
27 MIN
-
Jan 2025
